CORTEXYME Trademark

Trademark Overview


On Friday, December 11, 2015, a trademark application was filed for CORTEXYME with the United States Patent and Trademark Office. The USPTO has given the CORTEXYME trademark a serial number of 86847172. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Thursday, January 12, 2023. This trademark is owned by Cortexyme, Inc. The CORTEXYME trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Medical research; medical research services in the fields of Alzheimer's, brain disorders, neurological disorders, [ arthritis, ] infectious diseases, [ autoimmune diseases, ] inflammatory diseases, [ genetic diseases, diabetes, ] cardiovascular diseases, cancers, and other types of diseases and disorders; conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, [ arthritis, ] infectious diseases, [ autoimmune diseases, ] inflammatory diseases, [ genetic diseases, diabetes, ] cardiovascular diseases, cancers, and other types of diseases and disorders; medical and scientific study and research; pharmaceutical research and development; pharmaceutical and biological research, testing, and product development consultation
cortexyme

General Information


Serial Number86847172
Word MarkCORTEXYME
Filing DateFriday, December 11, 2015
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateThursday, January 12, 2023
Registration Number5007662
Registration DateTuesday, July 26, 2016
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2016

Trademark Statements


Goods and ServicesMedical research; medical research services in the fields of Alzheimer's, brain disorders, neurological disorders, [ arthritis, ] infectious diseases, [ autoimmune diseases, ] inflammatory diseases, [ genetic diseases, diabetes, ] cardiovascular diseases, cancers, and other types of diseases and disorders; conducting clinical trials for others in the fields of Alzheimer's, brain disorders, neurological disorders, [ arthritis, ] infectious diseases, [ autoimmune diseases, ] inflammatory diseases, [ genetic diseases, diabetes, ] cardiovascular diseases, cancers, and other types of diseases and disorders; medical and scientific study and research; pharmaceutical research and development; pharmaceutical and biological research, testing, and product development consultation

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, December 17, 2015
Primary Code042
First Use Anywhere DateWednesday, October 23, 2013
First Use In Commerce DateWednesday, October 23, 2013

Trademark Owner History


Party NameQUINCE THERAPEUTICS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCortexyme, Inc
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCortexyme, Inc
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Party NameCortexyme, Inc
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080

Trademark Events


Event DateEvent Description
Wednesday, December 12, 2018APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Tuesday, December 15, 2015NEW APPLICATION ENTERED
Thursday, December 17, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, March 28, 2016ASSIGNED TO EXAMINER
Monday, March 28, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 20, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2016PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 26, 2016REGISTERED-PRINCIPAL REGISTER
Wednesday, December 12, 2018TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 9, 2020TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, December 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, December 9, 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, July 26, 2021COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, June 27, 2022TEAS SECTION 8 & 15 RECEIVED
Wednesday, October 26, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, January 12, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, January 12, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Thursday, June 27, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, June 27, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, June 27, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, June 27, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, June 27, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, January 12, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED